Early surfactant for breathing problems in premature babies
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial gives a medication called surfactant early (when oxygen needs are slightly increased) to very premature babies with breathing trouble. It aims to see if this early treatment helps them breathe better without needing a breathing tube, potentially improving their outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Babies born between 26 and 31 weeks + 6 days of pregnancy
- Has signs of breathing trouble and a chest X-ray or lung ultrasound showing lung problems typical of a condition called respiratory distress syndrome (RDS)
- Must be admitted to the NICU within 3 hours after birth
- Needs non-invasive breathing support (a mask or nasal prongs, not a breathing tube)
- Parents or guardians must agree to the study in writing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
This study tests a lung medication called pulmonary surfactant, given with different oxygen levels, to help very premature babies (born before 32 weeks) who have breathing difficulties. The goal is to see which oxygen level works best with non-invasive breathing support.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
Hear when a new Respiratory Distress Syndrome (&Amp; [Hyaline Membrane Disease]) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.